Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

Go back to Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
(NASDAQ: STLN) Delayed: 6.83 +0.20 (3.02%)
Previous Close $6.63    52 Week High $ 
Open $6.67    52 Week Low $ 
Day High $6.95    P/E N/A 
Day Low $6.62    EPS $ 
Volume 1,454,070       

TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) Delayed: 5.13 --0 (-0%)
Previous Close $5.13    52 Week High $7.47 
Open $5.13    52 Week Low $7.47 
Day High $5.13    P/E N/A 
Day Low $5.13    EPS $0.00 
Volume 3,271,599       

(NASDAQ: TOIIW) Delayed: 0.05 --0 (-0%)
Previous Close $0.05    52 Week High $ 
Open $0.05    52 Week Low $ 
Day High $0.05    P/E N/A 
Day Low $0.05    EPS $ 
Volume 3,271,599